A comparison of hepatitis B seroepidemiology in ten European countries

To inform current and future vaccination strategies, we describe the seroepidemiology of hepatitis B virus (HBV) infection in ten representative European countries using standardized serology that allowed international comparisons. Between 1996 and 2003, national serum banks were compiled by collecting residual sera or by community sampling; sera were then tested by each country using its preferred enzyme immunoassays and testing algorithm, and assay results were standardized. Information on current and past HBV vaccination programmes in each country was also collected. Of the ten countries, six reported low levels

A comparison of hepatitis B seroepidemiology in ten European countries

none23NARDONE A; ANASTASSOPOULOU CG; THEETEN H; KRIZ B; DAVIDKIN I; THIERFELDER W; O'FLANAGAN D; BRUZZONE B; MOSSONG J; BOOT HJ; BUTUR D; SLACIKOVÁ M; PANAIT ML; HELLENBRAND W; DE MELKER H; SOBOTOVÁ Z; G. ICARDI; ANDREWS N; PEBODY RG; VAN DAMME P; KAFATOS G; MILLER E; HATZAKIS ANardone, A; Anastassopoulou, Cg; Theeten, H; Kriz, B; Davidkin, I; Thierfelder, W; O'Flanagan, D; Bruzzone, B; Mossong, J; Boot, Hj; Butur, D; Slaciková, M; Panait, Ml; Hellenbrand, W; DE MELKER, H; Sobotová, Z; Icardi, Giancarlo; Andrews, N; Pebody, Rg; VAN DAMME, P; Kafatos, G; Miller, E; Hatzakis, A